Benefits and risks of add-on therapies for Alzheimer's disease.

about

Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.

P2860

Q38737187-DEF061F3-367F-4002-8F26-7BED56998670

P2860

Benefits and risks of add-on therapies for Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q38620338

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Benefits and risks of add-on therapies for Alzheimer's disease.

@en

type

Item

label

Benefits and risks of add-on therapies for Alzheimer's disease.

@en

prefLabel

Benefits and risks of add-on therapies for Alzheimer's disease.

@en

P1476

Benefits and risks of add-on therapies for Alzheimer's disease.

@en

P2093

Radoslaw Magierski

http://www.w3.org/2001/XMLSchema#string

Tomasz Sobow

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

Long-term course and effectiveness of combination therapy in Alzheimer disease

The relationship between executive function and falls and gait abnormalities in older adults: a systematic review

Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways

Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease

Pharmacological management of behavioral symptoms associated with dementia

Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

P304

445-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NMT.15.39

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283446340

http://www.w3.org/2001/XMLSchema#string

P698

26517312

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Benefits and risks of add-on therapies for Alzheimer's disease.

about

P2860

P2860

Benefits and risks of add-on therapies for Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921